Event
26th Sidley China Life Sciences Roundtable
Wednesday, June 4, 2025 – Friday, June 6, 2025
Event Details
DateWednesday, June 4, 2025 – Friday, June 6, 2025
Beijing | Wednesday, June 4, 2025
The Ritz-Carlton, Beijing
Ballroom 1 (B1 Floor)
8:30 a.m. CST (check-in)
9:00 a.m. – 12:30 p.m. CST
Lunch to follow
Shanghai | Friday, June 6, 2025
The Ritz-Carlton Shanghai, Pudong
Amber Room (Level 3)
8:30 a.m. CST (check-in)
9:00 a.m. – 12:30 p.m. CST
Lunch to follow
RSVP here.

This half-day benchmarking event provides an intimate setting for lawyers and compliance officers to engage in an interactive dialogue on the following topics:
- From 2015 to 2025: A 10-year Overview of China’s Life Sciences Regulations — What’s Happened and What’s Next
- What “Sanctions” Mean: International Trade Compliance for Pharmaceutical and Medical Device Companies
- U.S. Outbound Investment Rules and America First Investment Policy: Impacts on Chinese Biotechs
- An introduction to the U.S. FDA Guidance for Use of AI in Drug Developments
- Compliance Essentials for Life Sciences Companies in Hong Kong
Speakers
- Chen Yang, Senior Counsel, Sidley
- Lei Li, Partner, Sidley
- Ruchun Ji, Partner, Sidley
- Shu Min Ho, Partner, Sidley
Should you have any questions, please contact sidleychinalifesciencesroundtable@sidley.com.
Contacts

Offices
Related Resources
Related Blogs
Capabilities
Suggested News & Insights
Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Swiss MedTech 2026Tuesday, August 25, 2026Bay Area Life Sciences RoundtableWednesday, July 22, 2026OIG Signals Further Support for Manufacturer-Sponsored Testing Programs with Fourth Favorable Advisory OpinionJuly 8, 2026Sidley Adds Mayan Katz to Emerging Companies and Venture Capital and Global Life Sciences Practices in New YorkJuly 8, 2026U.S. Clinical Trials: Federal Government Considers Safe Harbors to Encourage Enrollment and RetentionJuly 7, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


